Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2001Journal of Clinical Oncology

Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results

View Full Paper
Ask AI
Bookmark
Share

Authors

OBOscar S. BreathnachBeaumont HospitalBFBoris FreidlinNational Cancer InstituteBCBarbara A. ConleyNational Cancer Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Breathnach et al. (2001) studied this question.

synapsesocial.com/papers/6a83fdb8902d1005cc4a112fhttps://doi.org/10.1200/jco.2001.19.6.1734
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.1985 · 108 citations
  2. 2Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.1998 · 562 citations